Zentalis Pharmaceuticals, Inc. (ZNTL)
3.80
-0.08
(-2.06%)
USD |
NASDAQ |
Aug 28, 16:00
3.80
0.00 (0.00%)
After-Hours: 20:00
Zentalis Pharmaceuticals EPS Diluted (Quarterly) : -0.5929 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.5929 |
| March 31, 2026 | -0.5031 |
| December 31, 2025 | -0.4914 |
| September 30, 2025 | -0.37 |
| June 30, 2025 | -0.3733 |
| March 31, 2025 | -0.6736 |
| December 31, 2024 | -0.6664 |
| September 30, 2024 | -0.5647 |
| June 30, 2024 | -1.243 |
| March 31, 2024 | 0.1414 |
| December 31, 2023 | -0.8608 |
| September 30, 2023 | -0.7864 |
| June 30, 2023 | -1.851 |
| March 31, 2023 | -1.066 |
| December 31, 2022 | -0.9273 |
| Date | Value |
|---|---|
| September 30, 2022 | -0.9576 |
| June 30, 2022 | -1.337 |
| March 31, 2022 | -1.306 |
| December 31, 2021 | -1.113 |
| September 30, 2021 | -0.094 |
| June 30, 2021 | -1.340 |
| March 31, 2021 | -1.236 |
| December 31, 2020 | -0.982 |
| September 30, 2020 | -0.9103 |
| June 30, 2020 | -0.7818 |
| March 31, 2020 | -0.4495 |
| December 31, 2019 | -0.4043 |
| September 30, 2019 | -2.204 |
| June 30, 2019 | -0.2918 |
| March 31, 2019 | -0.2325 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ARS Pharmaceuticals, Inc. | -0.6277 |
| ACADIA Pharmaceuticals, Inc. | 0.1822 |
| Alnylam Pharmaceuticals, Inc. | 1.207 |
| Anika Therapeutics, Inc. | 0.2412 |
| Savara, Inc. | -0.1587 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -42.29M |
| Total Expenses (Quarterly) | 42.29M |
| Enterprise Value | 135.42M |
| Earnings Yield | -51.51% |
| Normalized Earnings Yield | -51.83 |